{"name": "Tobira Therapeutics",
 "permalink": "tobira-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/tobira-therapeutics",
 "homepage_url": "http://www.tobiratherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "jcrombie@tobiratherapeutics.com",
 "phone_number": "732-863-5980",
 "description": "",
 "created_at": "Fri Oct 01 04:50:23 UTC 2010",
 "updated_at": "Tue Sep 11 03:09:10 UTC 2012",
 "overview": "\u003Cp\u003ETobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[149,
       105],
      "assets/images/resized/0010/3787/103787v1-max-150x150.jpg"],
     [[149,
       105],
      "assets/images/resized/0010/3787/103787v1-max-250x250.jpg"],
     [[149,
       105],
      "assets/images/resized/0010/3787/103787v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Chairman",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Andrew",
      "last_name": "Hindman",
      "permalink": "andrew-hindman",
      "image": null}},
   {"is_past": false,
    "title": "EVP \u0026 CEO",
    "person":
     {"first_name": "Caroline",
      "last_name": "Loewy",
      "permalink": "caroline-loewy",
      "image": null}},
   {"is_past": true,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "James",
      "last_name": "Sapirstein",
      "permalink": "james-sapirstein",
      "image": null}},
   {"is_past": true,
    "title": "Founding CEO",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$31M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.tobiratherapeutics.com/pdfs/Tobira_Therapeutics_Series.pdf",
    "source_description": "Tobira Therapeutics Inc. Raises $31 Million in Series B Financing",
    "raised_amount": 31000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Frazier Healthcare Ventures",
         "permalink": "frazier-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/2779/32779v1-max-150x150.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-250x250.png"],
             [[153,
               72],
              "assets/images/resized/0003/2779/32779v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Montreux Equity Partners",
         "permalink": "montreaux-equity-partners",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0005/0252/50252v3-max-150x150.jpg"],
             [[250,
               88],
              "assets/images/resized/0005/0252/50252v3-max-250x250.jpg"],
             [[450,
               159],
              "assets/images/resized/0005/0252/50252v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "198 Route 9 North",
    "address2": "Suite 200",
    "zip_code": "07726 ",
    "city": "Manalapan",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}